Health Care Select Sector SPDR® ETF (XLV)
79.66
-0.73 -0.91%
NYSE Arca
Jun 27, 20:00
Delayed 2m
USD
XLV Key Stats
| Expense Ratio | 0.14% |
| Share Class Assets Under Management | 17.38B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 79.64 |
| Discount or Premium to NAV | 0.03% |
| Turnover Ratio | 8.00 |
View All XLV News
XLV News
-
WireHeadlineTime (ET)
-
Yahoo06/27 18:49
-
Yahoo06/27 16:21
-
Yahoo06/27 16:14
-
Yahoo06/27 15:07
-
SA Breaking News06/27 14:13
-
Yahoo06/27 14:13
-
Yahoo06/27 14:10
-
MT Newswires06/27 13:21
-
Yahoo06/27 12:20
-
MT Newswires06/27 09:26
XLV Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | 5.38% | 7.37% | 44 |
| 3M | 7.36% | 9.55% | 49 |
| 6M | 15.33% | 18.84% | 69 |
| 1Y | 18.35% | 23.68% | 77 |
| 3Y | 10.91% | 9.71% | 27 |
| 5Y | 18.14% | 18.37% | 47 |
Returns for periods of 1 year and above are annualized.
XLV Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.02% | 0.02% | 0.00 |
| Stock | 99.98% | 99.98% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | 0.00 | 0.00 | 0.00 |
XLV Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00 |
| Greater Europe | 0.00 |
| United Kingdom | 0.00 |
| Europe Developed | 0.00 |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 0.00 |
| Japan | 0.00 |
| Australasia | 0.00 |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00 |
Region breakdown data is calculated by using the long position holdings of the portfolio.
XLV Stock Sector Exposure
| Basic Materials | 0.00 |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 99.36% |
| Industrials | 0.00 |
| Real Estate | 0.00 |
| Technology | 0.64% |
| Utilities | 0.00 |
XLV Stock Market Capitalization
| Giant | 48.76% |
| Large | 42.25% |
| Medium | 8.72% |
| Small | 0.28% |
| Micro | 0.00 |
XLV Stock Style Exposure
| Large Cap Value | 30.79% |
| Large Cap Blend | 27.10% |
| Large Cap Growth | 33.12% |
| Mid Cap Value | 1.86% |
| Mid Cap Blend | 3.17% |
| Mid Cap Growth | 3.68% |
| Small Cap Value | 0.00 |
| Small Cap Blend | 0.28% |
| Small Cap Growth | 0.00 |
View More Holdings
As of June 26, 2017
XLV Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 11.97% | 135.01 | -0.98% |
| PFE | Pfizer Inc | 6.62% | 33.77 | -0.79% |
| MRK | Merck & Co Inc | 5.88% | 65.54 | -0.58% |
| UNH | UnitedHealth Group Inc | 5.86% | 184.60 | -0.28% |
| AMGN | Amgen Inc | 4.17% | 170.85 | -1.62% |
| MDT | Medtronic PLC | 4.00% | 88.79 | -0.40% |
| ABBV | AbbVie Inc | 3.77% | 72.39 | -0.48% |
| CELG | Celgene Corp | 3.40% | 130.85 | -2.24% |
| BMY | Bristol-Myers Squibb Company | 3.07% | 55.90 | -1.79% |
| GILD | Gilead Sciences Inc | 3.03% | 70.65 | -0.83% |
Advertisement
XLV Ratings
| Fiduciary Score | Upgrade |
XLV One Page Reports
- One Page Report Download
XLV Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Benchmark Index | |
|---|---|
S&P Health Care Select Sector TR USD |
100.0% |
XLV Manager Info
| Name | Tenure |
|---|---|
| Dwayne Hancock | 0.32 yrs |
| Karl Schneider | 2.25 yrs |
| Michael Feehily | 6.25 yrs |
XLV Net Fund Flows
| 1M | -6.758M |
| 3M | -132.32M |
| 6M | 1.089B |
| YTD | 1.206B |
| 1Y | 2.708B |
| 3Y | 4.064B |
| 5Y | 5.987B |
| 10Y | 7.969B |
XLV Risk Info
| Beta (5Y) | 0.9244 |
| Max Drawdown (All) | 40.58% |
| Historical Sharpe (10Y) | 0.7146 |
| Historical Sortino (All) | 0.6888 |
| 30-Day Rolling Volatility | 8.99% |
| Daily Value at Risk (VaR) 1% (All) | 3.04% |
| Monthly Value at Risk (VaR) 1% (All) | 13.38% |
XLV Fundamentals
| Dividend Yield TTM (6-27-17) | 1.46% |
| SEC Yield (6-26-17) | 1.44% |
| Weighted Average PE Ratio | 22.41 |
| Weighted Average Price to Sales Ratio | 1.783 |
| Weighted Average Price to Book Ratio | 3.726 |
| Weighted Median ROE | 22.54% |
| Weighted Median ROA | 8.14% |
| Forecasted Dividend Yield | 1.76% |
| Forecasted PE Ratio | 19.77 |
| Forecasted Price to Sales Ratio | 1.651 |
| Forecasted Price to Book Ratio | 3.190 |
| Number of Holdings | 62 |
XLV Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.26% |
| Forecasted Book Value Growth | 9.17% |
| Forecasted Cash Flow Growth | 14.51% |
| Forecasted Earnings Growth | 11.47% |
| Forecasted Revenue Growth | 9.93% |
XLV Comparables
EditXLV Attributes
| Key Dates | |
|---|---|
| Inception Date | 12/16/1998 |
| Last Annual Report Date | 9/30/2016 |
| Last Prospectus Date | 1/31/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | Yes |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
XLV Excel Add-In Codes
- Name: =YCI("XLV","name")
- Broad Asset Class: =YCI("XLV", "broad_asset_class")
- Broad Category: =YCI("XLV", "broad_category_group")
- Prospectus Objective: =YCI("XLV", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
